Pharmacology, Toxicology and Pharmaceutical Science
Neoplasm
100%
Chemotherapy
55%
Malignant Neoplasm
46%
Breast Cancer
45%
Cisplatin
35%
Disease
24%
Ovary Cancer
23%
Pharmacokinetics
23%
Solid Malignant Neoplasm
22%
Small Cell Lung Cancer
18%
Carboplatin
16%
Biological Marker
16%
Carcinoid
15%
Tracer
15%
Zirconium 89
15%
P-Glycoprotein
15%
Ovary Carcinoma
14%
Gamma Urogastrone
13%
Non Small Cell Lung Cancer
12%
Cyclophosphamide
12%
Protein P53
12%
Drug Resistance
12%
Fluorouracil
12%
Doxorubicin
12%
Trastuzumab
11%
Glutathione
11%
Tumor Necrosis Factor Related Apoptosis Inducing Ligand
11%
Cytotoxicity
11%
High Dose Chemotherapy
10%
Bevacizumab
10%
DNA Topoisomerase (ATP Hydrolysing)
10%
Epidermal Growth Factor Receptor 2
10%
Biodistribution
10%
Overall Survival
10%
Serotonin
10%
Etoposide
10%
Uterine Cervix Cancer
9%
Death Receptor
9%
Colon Cancer
9%
Monoclonal Antibody
9%
Metastatic Breast Cancer
9%
Estrogen Receptor
9%
Clinical Trial
9%
Colorectal Cancer
8%
Remission
8%
Interleukin 6
8%
Placebo
8%
Testis Cancer
8%
Fluorine 18
8%
Anthracycline
8%
Medicine and Dentistry
Neoplasm
97%
Breast Cancer
60%
Positron Emission Tomography
35%
Malignant Neoplasm
35%
Positron Emission Tomography
28%
Ovarian Cancer
23%
Disease
23%
Cisplatin
23%
Radioactive Tracer
19%
Zirconium 89
18%
Molecular Imaging
18%
Biological Marker
16%
Oncology
14%
ABC Transporter Subfamily B
14%
Radiation Therapy
14%
Cancer Therapy
14%
Programmed Cell Death
13%
Gamma Urogastrone
13%
Krukenberg Tumor
13%
Metastatic Carcinoma
13%
In Vitro
13%
Carcinoid
12%
Estrogen Receptor
12%
Metastatic Breast Cancer
12%
Bevacizumab
11%
Tumor Cell
11%
Cancer Cell
11%
Epidermal Growth Factor Receptor 2
10%
Cell Line
10%
Overall Survival
10%
Positron Emission Tomography-Computed Tomography
10%
Cervical Cancer
9%
Clinical Trial
9%
Biodistribution
9%
Trastuzumab
9%
High Dose Chemotherapy
9%
Colorectal Cancer
9%
Cyclophosphamide
9%
Medical Oncology
9%
Small Cell Lung Cancer
9%
Solid Malignant Neoplasm
8%
Carboplatin
8%
Tamoxifen
8%
Lung Cancer Cell Line
8%
Doxorubicin
8%
Receptor Expression
8%
Colon Cancer
8%
Medicine
8%
Nodular Melanoma
7%
Isotopes of Calcium
7%
Keyphrases
Chemotherapy
7%
Positron Emission Tomography
7%
Tumor
7%
Oncology
6%
Zirconium-89 (89Zr)
5%
Cisplatin
5%
Phase II Study
5%
Breast Cancer
5%
